Effect of Cytoreductive Chemotherapy and a CCR5 Coreceptor Antagonist on HIV-1 Eradication
Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy
A Phase I/II Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004
Lovastatin: Immunomodulatory Value Evaluation
† Study has passed its completion date and status has not been verified in more than two years.